OpenClinical logo

Clinical demonstrators

Instruments, methods supporting the use of clinical applications

USA  GLIA
GLIA logo
Instrument to identify obstacles to guideline implementation
keywords clinical domains
Clinical practice guidelines, guideline appraisal, implementability multiple
developed by Yale Center for Medical Informatics, Yale University, New Haven, USA
released First release 2005
status Draft 1.0
download  bullet  GLIA: short registration required before the instrument can be sent by email [PDF format].
description
GLIA (GuideLine Implementability Appraisal) is a tool designed to help appraise the implementability of a clinical guideline, i.e. identify any potential obstacles to its being implemented. "In addition to a series of questions that inquire about the global aspects of a guideline's implementability, the instrument explores the following dimensions:
  • Decidability
  • Executability
  • Effect On Process Of Care
  • Presentation & Formatting
  • Measurable Outcomes
  • Apparent Validity
  • Novelty/Innovation
  • Flexibility
  • Computability"

For further information, see references section below.

references

Shiffman RN, Dixon J, Brandt C et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005 Jul 27;5:23.

[PubMed]   [PubMed Central]

" BACKGROUND: Clinical practice guidelines are not uniformly successful in influencing clinicians' behaviour toward best practices. Implementability refers to a set of characteristics that predict ease of (and obstacles to) guideline implementation. Our objective is to develop and validate a tool for appraisal of implementability of clinical guidelines. METHODS: Indicators of implementability were identified from the literature and used to create items and dimensions of the GuideLine Implementability Appraisal (GLIA). GLIA consists of 31 items, arranged into 10 dimensions. Questions from 9 of the 10 dimensions are applied individually to each recommendation of the guideline. Decidability and Executability are critical dimensions. Other dimensions are Global, Presentation and Formatting, Measurable Outcomes, Apparent Validity, Flexibility, Effect on Process of Care, Novelty/Innovation, and Computability. We conducted a series of validation activities, including validation of the construct of implementability, expert review of content for clarity, relevance, and comprehensiveness, and assessment of construct validity of the instrument. Finally, GLIA was applied to a draft guideline under development by national professional societies. RESULTS: Evidence of content validity and preliminary support for construct validity were obtained. The GLIA proved to be useful in identifying barriers to implementation in the draft guideline and the guideline was revised accordingly. CONCLUSION: GLIA may be useful to guideline developers who can apply the results to remedy defects in their guidelines. Likewise, guideline implementers may use GLIA to select implementable recommendations and to devise implementation strategies that address identified barriers. By aiding the design and operationalization of highly implementable guidelines, our goal is that application of GLIA may help to improve health outcomes, but further evaluation will be required to support this potential benefit. "

contact Prof. Richard Shiffman
Yale Center for Medical Informatics
PO Box 208009
New Haven
CT 06520-8009, USA

links  bullet  GLIA  bullet  Yale Center for Medical Informatics
acknowledgements
Rick Shiffman, Yale Center for Medical Informatics
page history
Entry on OpenClinical: 31 August 2005
Last main update: 19 September 2005
Design - template v0.2: 24 June 2005.

 

Search this site
 
Privacy policy User agreement Copyright Feedback

Last modified:
© Copyright OpenClinical 2001-2009